Publications by authors named "Kamal Bouadballah"
Bone Marrow Transplant
July 2021
Article Synopsis
- - The LyMA trial shows that rituximab maintenance after autologous stem cell transplantation (ASCT) enhances outcomes for previously untreated mantle-cell lymphoma (MCL) patients, comparing different platinum derivatives used in the treatment.
- - Among the various platinum derivatives, R-DHAOx demonstrated superior progression-free survival (PFS) and overall survival (OS) rates compared to R-DHACis and R-DHACa, with 4-year OS rates of 92% for R-DHAOx versus 75.9% for the others.
- - Low MIPI score and the use of R-DHAOx are identified as independent favorable prognostic markers for both PFS and OS in young MCL patients eligible
